JP2025506487A5 - - Google Patents
Info
- Publication number
- JP2025506487A5 JP2025506487A5 JP2024547502A JP2024547502A JP2025506487A5 JP 2025506487 A5 JP2025506487 A5 JP 2025506487A5 JP 2024547502 A JP2024547502 A JP 2024547502A JP 2024547502 A JP2024547502 A JP 2024547502A JP 2025506487 A5 JP2025506487 A5 JP 2025506487A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- composition according
- larazotide
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263308330P | 2022-02-09 | 2022-02-09 | |
| US63/308,330 | 2022-02-09 | ||
| PCT/US2023/062247 WO2023154770A1 (en) | 2022-02-09 | 2023-02-09 | Compositions and methods for inhibiting rho kinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506487A JP2025506487A (ja) | 2025-03-11 |
| JP2025506487A5 true JP2025506487A5 (cg-RX-API-DMAC7.html) | 2026-02-17 |
Family
ID=87565095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547502A Pending JP2025506487A (ja) | 2022-02-09 | 2023-02-09 | Rhoキナーゼを阻害する組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250144166A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4475867A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025506487A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119730867A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3243960A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023154770A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118873629B (zh) * | 2024-09-27 | 2024-12-10 | 北京大学口腔医学院 | 醋酸拉唑肽在制备促进成骨药物中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009047532A2 (en) * | 2007-10-12 | 2009-04-16 | Cancer Research Technology Limited | Cancer susceptibility loci |
| WO2009132050A2 (en) * | 2008-04-21 | 2009-10-29 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| JP2020507626A (ja) * | 2017-02-10 | 2020-03-12 | イノベイト バイオファーマシューティカルズ インコーポレイテッド | 腸上皮の透過性と関連する疾患を治療する組成物及び方法 |
| WO2019183036A1 (en) * | 2018-03-19 | 2019-09-26 | Innovate Biopharmaceuticals, Inc. | Compositions and methods for potentiating immune checkpoint inhibitor therapy |
| KR20220049005A (ko) * | 2019-08-16 | 2022-04-20 | 9 미터스 바이오파마, 인코포레이티드 | 라라조타이드 제형 |
| AU2021255955A1 (en) * | 2020-04-15 | 2022-11-10 | Interlude Biopharma Co. | Larazotide derivatives comprising d-amino acids |
-
2023
- 2023-02-09 CA CA3243960A patent/CA3243960A1/en active Pending
- 2023-02-09 US US18/836,845 patent/US20250144166A1/en active Pending
- 2023-02-09 EP EP23753638.8A patent/EP4475867A4/en active Pending
- 2023-02-09 WO PCT/US2023/062247 patent/WO2023154770A1/en not_active Ceased
- 2023-02-09 JP JP2024547502A patent/JP2025506487A/ja active Pending
- 2023-02-09 CN CN202380032652.0A patent/CN119730867A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI846665B (zh) | 用於起因於剪接異常之遺傳性疾病的醫藥組合物及治療方法 | |
| US11976334B2 (en) | Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease | |
| ES2906227T3 (es) | Potenciador de efecto antitumoral | |
| JP6895251B2 (ja) | レトロウイルスにより引き起こされる疾患を処理する為に有用な化合物 | |
| Velagapudi et al. | Design and synthesis of poly (ADP-ribose) polymerase inhibitors: impact of adenosine pocket-binding motif appendage to the 3-oxo-2, 3-dihydrobenzofuran-7-carboxamide on potency and selectivity | |
| TW200927113A (en) | Qninoline derivatives for modulating DNA methylation | |
| ES2953005T3 (es) | Tratamiento para el cáncer | |
| CN107613983A (zh) | 抗肿瘤剂的副作用减轻剂 | |
| US9321759B2 (en) | Methods and use of bifunctional enzyme-building clamp-shaped molecules | |
| JP2024164126A (ja) | 有機化合物 | |
| EP3590941A1 (en) | Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof | |
| WO2019011293A1 (zh) | 靶向于pd-1的皂苷类化合物及其应用 | |
| US10220072B2 (en) | Mesalamine for the treatment of cancer | |
| WO2024175042A1 (zh) | 药物偶联物治疗肿瘤疾病的用途及方法 | |
| Częścik et al. | Evolution or revolution in colorectal cancer treatment: present and future of new therapeutic options. A narrative review | |
| US10857113B2 (en) | Bezafibrate for the treatment of cancer | |
| CN119730867A (zh) | 用于抑制rho激酶的组合物和方法 | |
| ZHANG et al. | The therapeutic effect of histone deacetylase inhibitor and PD98059 conjugate on cutaneous squamous cell carcinoma | |
| Yang et al. | Review of systemic therapy options for the treatment of cholangiocarcinoma in Canada. | |
| HK1245640B (en) | Agent for alleviating adverse reaction to antitumor drug | |
| TW202535398A (zh) | 用於治療癌症之包含光學活性氮雜雙環衍生物之醫藥 | |
| KR20260058839A (ko) | 5-할로우라실로 변형된 이중가닥 핵산 및 이의 암 치료에서의 용도 | |
| EP4717277A1 (en) | Use of drug conjugate in treating tumor disease and method therefor | |
| WO2014139391A1 (en) | Substituted pyridine compounds as kinases inhibitors | |
| TWI326281B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |